Testing Anktiva for long COVID symptoms
Part of Infections, Lungs & breathing clinical trials.
This study tests if the drug Anktiva can help people with long COVID. To join, you must have had at least one confirmed COVID-19 infection and now have lasting symptoms that started or got worse after that infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 69 years old.
- You had at least one confirmed COVID-19 infection (a positive test).
- You have at least 2 long COVID symptoms (like fatigue, brain fog, or chest pain) that started or got worse after your COVID infection.
- Your symptoms have been present for at least 60 days, and it has been at least 90 days since your last COVID infection.
- You are not currently hospitalized and are in otherwise stable health.
- You do not have autoimmune diseases, active heart problems, diabetes, or other major health conditions listed in the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
This trial tests whether a combination of two existing drugs, maraviroc and atorvastatin, can help reduce long covid symptoms like fatigue, brain fog, and shortness of breath. It aims to improve daily functioning for people who have had symptoms for more than six months.
This study tests whether a combination of antiviral medications can help reduce Long COVID symptoms by targeting viruses that may stay in the body. If you have Long COVID, this treatment might help you feel better.
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.